APM
APM
NASDAQ · Biotechnology

Aptorum Group Ltd-Class A

$0.81
+0.07 (+9.06%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.16M 3.05M 3.43M
Net Income -41,291 -50,098 -44,694
EPS
Profit Margin -1.3% -1.6% -1.3%
Rev Growth +21.0% -5.0% +24.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 776.3K 904.7K 890.0K
Total Equity 2.22M 2.33M 2.52M
D/E Ratio 0.35 0.39 0.35
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -71,807 -61,818 -76,890
Free Cash Flow -34,920 -36,621 -42,296